“…[18][19][20][21][109][110][111] Overexpression (OE) of pathogenic LRRK2 mutants, such as G2019S, R1441C, or R1441G, induces PD-like phenotypes, including age-dependent DA neuronal loss, disruption of dopamine homeostasis, L-DOPA responsive locomotor defects, and pathological accumulations of tau and α-syn. 15,[112][113][114][115][116][117] While OE models enable the investigation of PD neurodegenerative features, they are limited by potential overexpressionrelated artifacts. Previous studies have also examined the combined effect of ageing, environmental toxicity, and LRRK2related genetic vulnerability.…”